SKI Market

Indian Indices

Nifty

25,910.05 -103.40
(-0.40%)

Sensex

84,673.02 -277.93
( -0.33%)

Bank Nifty

58,899.25 -63.45
( -0.11%)

Nifty IT

35,975.20 -400.00
( -1.10%)

Global Indices

Nasdaq

46,604.53 -563.95
(-1.20%)

Dow Jones

6,692.71 -62.40
(-0.92%)

Hang Seng

48,833.62 -1,490.29
(-2.96%)

Nikkei 225

9,695.49 -2.88
(-0.03%)

Forex

USD-INR

88.65 -0.06
(-0.07%)

EUR-INR

103.02 -0.02
(-0.02%)

GBP-INR

116.73 0.00
(0.00%)

JPY-INR

0.57 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

62.7662681

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

17.15

126.95

EPS(TTM)

Face Value()

Div & Yield %

4.65

1.5

Back

Plastiblends India standalone net profit rises 17.91% in the September 2025 quarter

Oct 17,2025

Net profit of Plastiblends India rose 17.91% to Rs 7.44 crore in the quarter ended September 2025 as against Rs 6.31 crore during the previous quarter ended September 2024. Sales rose 3.92% to Rs 192.61 crore in the quarter ended September 2025 as against Rs 185.35 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	192.61	185.35	4
OPM %	5.64	5.28	-
PBDT	13.82	12.10	14
PBT	10.01	8.29	21
NP	7.44	6.31	18

25,910.05 -103.40 (-0.40%)

84,673.02 -277.93 ( -0.33%)

58,899.25 -63.45 ( -0.11%)

35,975.20 -400.00 ( -1.10%)

46,604.53 -563.95 (-1.20%)

6,692.71 -62.40 (-0.92%)

48,833.62 -1,490.29 (-2.96%)

9,695.49 -2.88 (-0.03%)

88.65 -0.06 (-0.07%)

103.02 -0.02 (-0.02%)

116.73 0.00 (0.00%)

0.57 0.00 (-0.02%)